Network News
The shortlist of the Cancer Grand Challenges selection process 2025 has been announced and Roman Sarott, Research Group Leader at the Max Planck Institute for Medical Research, Heidelberg and Heilbronn, has been selected for the final stages as part of team NeoCircuit. The team tackles the challenge of developing and applying novel ways to rewire cancer […]
read more
Not all ALK fusions act the same: Variants influence treatment success in lung cancer
About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all patients with these fusions the same way. However, new research led by scientists from the […]
read more
Therapeutic vaccination against HPV-related tumors: Nanoparticles make the difference
Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. In a mouse […]
read more
ERC Awards Four Starting Grants to Universität Heidelberg
European Research Council funds groundbreaking projects by early-career researchers The European Research Council is awarding four valuable grants to Heidelberg University. These ERC Starting Grants go to researchers in early stages of their career who want to carry out groundbreaking research with ERC funding. They include Dr Michael Gerlt, who will do research at the […]
read more
BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model. Heidelberg, Germany, August 19th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, […]
read more
FOXP1 syndrome: Potential therapeutic approach discovered for rare language development disorder
FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. To date, there are no treatments that target the root cause of the disorder. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition […]
read more
International Research Award in Dentistry goes to Heidelberg Institute of Global Health
A great honor for Professor Dr. Dr. Stefan Listl from the Medical Faculty of Heidelberg University: The International Association for Dental, Oral, and Craniofacial Research (IADR) honored him at its annual meeting with the prestigious Distinguished Scientist Award in the field of social science, epidemiology, and health services research. This award is one of the […]
read more
Possible target for new immunotherapy
A research team led by the German Cancer Research Center (DKFZ) and the Luxembourg Institute of Health has found a key mechanism that weakens the immune system in chronic lymphocytic leukemia (CLL). The scientists were able to show that the protein galectin-9 plays a key role in blocking the function of T cells, which are […]
read more
New Collaborative Research Centre on Cancers of Blood-Forming Bone Marrow
DFG funds research consortium at the Medical Faculty Heidelberg with around 15.8 million euros – A new Collaborative Research Centre based at the Medical Faculty Heidelberg is going to start at Heidelberg University. In its recent approval round, the German Research Foundation (DFG) decided to support CRC 1709 “Cellular Plasticity in Malignant Myeloid Diseases – […]
read more
